SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001824293-23-000033
Filing Date
2023-03-31
Accepted
2023-03-31 16:35:00
Documents
15
Period of Report
2023-03-31
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K val-20230331.htm   iXBRL 8-K 34344
5 GRAPHIC val-20230331_g1.jpg GRAPHIC 16879
6 GRAPHIC val-20230331_g2.jpg GRAPHIC 1656
7 GRAPHIC val-20230331_g3.jpg GRAPHIC 95792
  Complete submission text file 0001824293-23-000033.txt   449067

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT val-20230331.xsd EX-101.SCH 1911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT val-20230331_lab.xml EX-101.LAB 25848
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT val-20230331_pre.xml EX-101.PRE 13588
9 EXTRACTED XBRL INSTANCE DOCUMENT val-20230331_htm.xml XML 4432
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40034 | Film No.: 23788437
SIC: 2834 Pharmaceutical Preparations